The Clinical and Laboratory Characteristics of Recurrent Drug- Related Hyponatremia (0597-10-HMO)

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified January 2012 by Hadassah Medical Organization
Sponsor:
Information provided by (Responsible Party):
Hadassah Medical Organization
ClinicalTrials.gov Identifier:
NCT01509170
First received: January 10, 2012
Last updated: NA
Last verified: January 2012
History: No changes posted
  Purpose

The aim of this study is to identify factors associated with hyponatremia among patients hospitalized in the internal medicine ward. Consequtive patients hospitalized because of hyponatremia will be recruited. Follow up will include clinical factors such as background diseases, complete drug history, blood tests including Biochemistry tests (Sodium, renal function), endocrinological evaluation, thyroid function tests, cortisol,urinary sodium on addmition. One month following discharge follow up Sodium level will be taken.


Condition
Hyponatremia
SIADH

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Observational Cohort Study- The Clinical and Laboratory Characteristics of Recurrent Drug- Related

Further study details as provided by Hadassah Medical Organization:

Estimated Enrollment: 500
Study Start Date: February 2012
Estimated Study Completion Date: January 2017
Estimated Primary Completion Date: January 2015 (Final data collection date for primary outcome measure)
  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Consequtive patients hospitalized to the internal medicine ward due to hyponatremia

Criteria

Inclusion Criteria:

  • patients hospitalized to the internal medicine ward due to hyponatremia

Exclusion Criteria:

  • None
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01509170

Locations
Israel
Hadassah- Hebrew-University Medical Center Not yet recruiting
Jerusalem, Israel, 91120
Contact: Mordechai Muszkat, MD    97226777335    muszkatm@hadassah.org.il   
Principal Investigator: Mordechai Muszkat, MD         
Hadassah-Hebrew University Medical Center Not yet recruiting
Jerusalem, Israel, 91120
Contact: Mordechai Muszkat, MD    97226777335    muszkatm@hadassah.org.il   
Principal Investigator: Mordechai Muszkat, MD         
Sponsors and Collaborators
Hadassah Medical Organization
Investigators
Principal Investigator: Mordechai Muszkat, MD Hadassah Medical Organization
  More Information

No publications provided

Responsible Party: Hadassah Medical Organization
ClinicalTrials.gov Identifier: NCT01509170     History of Changes
Other Study ID Numbers: 0597-10-HMO, 0597
Study First Received: January 10, 2012
Last Updated: January 10, 2012
Health Authority: Israel: Ministry of Health

Additional relevant MeSH terms:
Hyponatremia
Inappropriate ADH Syndrome
Water-Electrolyte Imbalance
Metabolic Diseases
Pituitary Diseases
Hypothalamic Diseases
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Endocrine System Diseases

ClinicalTrials.gov processed this record on August 21, 2014